CVS Health stock heads into November 4 earnings test

CVS Health is scheduled to report its third-quarter 2026 results before US markets open on Wednesday, November 4. The upcoming release will give investors a fresh read on the healthcare group's insurance, pharmacy services and retail operations.

AlphaStreet News reported that a consensus of 23 analysts calls for earnings of 1.65 US dollars per share and revenue of 104.80 billion US dollars. The publication said the revenue forecast implies growth from the prior-year quarter, while the earnings estimate also points to a modest year-over-year increase.

Key Issues Beyond The Headline

Investors are likely to focus on the medical benefit ratio in Aetna, which indicates how insurance premium revenue is translating into medical costs. Pharmacy services margin trends and Medicare Advantage membership will also help clarify the earnings quality across CVS Health's main businesses.

Management commentary will be important after the results. Updates on fourth-quarter guidance, cost reduction efforts, capital allocation and the outlook for 2027 could matter as much as the headline figures.

CVS Health stock traded at 80.94 euros on Lang & Schwarz at 17:09 CET on Sunday, November 1, 2026. Investors can follow the real-time quote of CVS Health stock for subsequent trading updates.

Broader market sentiment will also shape attention around the S&P 500.

For the next catalyst, investors should watch the November 4 release and management's comments on insurance costs, pharmacy profitability and the 2027 outlook. More news and analyses on CVS Health stock provide further company coverage.